Acute myocardial infarction and influenza: A meta-analysis of case-control studies

Heart

Volumn 101, Issue 21, 2015, Pages 1738-1747

  Barnes, Michelle ^a   Heywood, Anita E ^a   Mahimbo, Abela ^a   Rahman, Bayzid ^a   Newall, Anthony T ^a   MaCintyre, C Raina ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; CASE CONTROL STUDY; DISEASE ASSOCIATION; FLU LIKE SYNDROME; HEART PROTECTION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; META ANALYSIS; PRIMARY PREVENTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SECONDARY PREVENTION; SYSTEMATIC REVIEW; COMPLICATION; INFLUENZA, HUMAN; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PREVENTIVE MEDICINE; PROCEDURES; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA;

INFLUENZA VACCINE;

CASE-CONTROL STUDIES; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PREVENTIVE MEDICINE; RISK ASSESSMENT;

EID: 84947241465     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-307691     Document Type: Article

References (45)

1. World Health Organisation. Global Health Estimates. 2014 Summary tables: Deaths by cause, age and sex, by WHO region, 2000-2012, 2014. Available at: http://www.who.int/healthinfo/global-burden-disease/estimates/en/index1.html (accessed 16 Feb 2015).
2. World Health Organisation. Global Atlas on cardiovascular disease prevention and control. Geneva: World Health Organisation, 2011. Available at: http://whqlibdoc.who.int/publications/2011/9789241564373-eng.pdf?ua=1 (accessed 16 Feb 2015).
3. Collins SD. Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Public Health Rep 1932;47:2159-80.
4. Wu P, Goldstein E, Ho LM, et al. Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009. J Infect Dis 2012;206:1862-71.
5. Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010;10:83-92.
6. Bermudez-Fajardo A, Oviedo-Orta E. Influenza vaccination promotes stable atherosclerotic plaques in apoE knockout mice. Atherosclerosis 2011;217: 97-105.
7. Warren-Gash C, Smeeth L, Haywood A. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systemic review. Lancet Infect Dis 2009;9:601-10.
8. Johnstone J, Loeb M, Teo K, et al. Ongoing Telmisartan Alone and in Combination With Ramipril Global EndPoint Trial (ONTARGET), Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease (TRANSCEND) Investigators. Influenza vaccination and major adverse vascular events in high-risk patients. Circulation 2012;126:278-86.
9. Ciszewski A, Bilinska Z, Brydak V, et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 2008;28:1350-8.
10. Phrommintikul A, Kuanprasert S, Wongcharoen W, et al. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 2011;32:1730-5.
11. Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 2013;310:1711-20.
12. Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook. 10th edn. Canberra: Australian Government Department of Health, 2013.
13. Grohskopf L, Shay D, Shimabukuro T, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2013-2014. MMWR Recomm Rep 2013;62:1-43.
14. Nicoll A, Tsolova S, for the ECDC SIIP Team. ECDC GUIDANCE: Priority risk groups for influenza vaccination. Stockholm: European Centre for Disease Prevention and Control, 2008.
15. Madjid M, Alfred A, Sahai A, et al. Factors contributing to suboptimal vaccination against influenza: results of a nationwide telephone survey of persons with cardiovascular disease. Tex Heart Inst J 2009;36:546-52.
16. Jimenez-Garcia R, Hernandez-Barrera V, de Andres AL, et al. Predictors of influenza vaccination uptake among adults with a history of heart attack. Hum Vaccin 2010;6:566-71.
17. Ajani U, Ford E, Okoro C, et al. Low prevalence of influenza vaccination among people with cardiovascular disease - BRFSS. Am J Prev Med 2005;29(5 Suppl 1):31-5.
18. Sanderson S, Tatt I, Higgins J. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol 2007;36:666-76.
19. Guyatta G, Oxmanb A, Vistb G, et al. GRADE guidelines: 4. Rating the quality of evidenced study limitations (risk of bias). J Clin Epidemiol 2011;64:e407-15.
20. Gordis L. Epidemiology. 5th edn. Elsevier Health Sciences, 2013.
21. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
22. Torvaldsen S, McIntyre PB. Observational methods in epidemiologic assessment of vaccine effectiveness. Commun Dis Intell 2002;26:451-7.
23. Higgins J, Thompson S, Deeks J, et al. Measuring inconsistency in meta-analyses. Br Med J 2003;327:557-60.
24. Begg C, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
25. Egger M, Davey S, Schneider M, et al. Bias in meta-analysis detected y a simple, graphical test. Br Med J 1997;315:629-34.
26. Ponka A, Jalanko H, Ponka T, et al. Viral and mycoplasmal antibodies in patients with myocardial infarction. Ann Clin Res 1981;13:429-32.
27. MacIntyre C, Heywood A, Kovoor P, et al. Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. Heart 2013;99:1843-8.
28. Warren-Gash C, Geretti A, Hamilton G, et al. Influenza-like illness in acute myocardial infarction patients during the winter wave of the influenza A H1N1 pandemic in London: a case-control study. BMJ Open 2013;3:pii: e002604.
29. Guan X, Yang W, Sun X, et al. Association of influenza virus infection and inflammatory cytokines with acute myocardial infarction. Inflamm Res 2012;61:591-8.
30. Mattila K. Viral and bacterial infections in patients with acute myocardial infarction. J Intern Med 1989;225:293-6.
31. Clayton T, Capps N, Stephens N, et al. Recent respiratory infection and the risk of myocardial infarction. Heart 2005;91:1601-2.
32. Clayton T, Thompson M, Meade T. Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database. Eur Heart J 2008;29:96-103.
33. Meier C, Jick S, Derby L, et al. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 1998;351:1467-71.
34. Penttinen J, Valonen P. The risk of myocardial infarction among Finnish farmers seeking medical care for an infection. Am J Public Health 1996;86:1440-2.
35. Spodick D, Flessas A, Johnson M. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984;53:481-2.
36. Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000;102:3039-45.
37. Puig-Barbera J, Diez-Domingo J, Varea A, et al. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine 2007;25:7313-21.
38. Siriwardena AN, Gwini SM, Coupland CA. Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study. CMAJ 2010;182:1617-23.
39. Meyers DG. Influenza and pneumococcal vaccinations fail to prevent myocardial infarction. Heart Drug 2004;4:96-100.
40. Heffelfinger JD, Heckbert SR, Psaty BM, et al. Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin 2006;2:161-6.
41. Tonelli M, Lloyd A, Clement F, et al. For the Alberta Kidney Disease Network. Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ 2011;183:E1189-E202.
42. Neal B, MacMahon S, Chapman N, Blood Pressure Lowering Treatment Trialists Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood pressure lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000;356:1955-64.
43. Capewell S, Critchley J. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2004;1:CD003041.
44. Newall AT, Kelly H, Harsley S, et al. Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group. Pharmacoeconomics 2009;27:439-50.
45. Nichol K, Nordin J, Nelson D, et al. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007;357:1373-81.